Aprogen Medicines Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	34,541	45,148	37,162	35,684	43,070	15,894
Short-Term Investments	-	-	-	-	-	4,000
Trading Asset Securities	5,921	5,612	6,500	5,000	4,390	-
Cash & Short-Term Investments	40,462	50,760	43,662	40,684	47,460	19,894
Cash Growth	-7.25%	16.26%	7.32%	-14.28%	138.57%	-91.62%
Accounts Receivable	27,083	25,976	19,674	24,809	21,389	1,567
Other Receivables	3,990	3,558	1,170	1,607	7,988	9,759
Receivables	52,623	60,612	24,356	34,637	92,306	56,990
Inventory	65,604	60,894	62,483	60,815	61,467	23,257
Prepaid Expenses	2,286	1,179	967.42	847.35	913.48	906.58
Other Current Assets	5,541	5,199	2,849	7,224	9,432	2,052
Total Current Assets	166,517	178,643	134,317	144,207	211,578	103,099
Property, Plant & Equipment	361,905	367,267	364,181	362,959	365,100	314,479
Long-Term Investments	12,717	19,296	9,790	2,447	3,298	54,786
Goodwill	50,958	50,958	-	-	-	-
Other Intangible Assets	17,386	17,415	6,106	7,489	8,431	2,633
Long-Term Deferred Tax Assets	2,837	2,683	-	-	662.84	-
Long-Term Deferred Charges	55,202	54,420	46,601	34,625	4,988	-
Other Long-Term Assets	22,054	22,788	3,902	1,224	5,222	1,904
Total Assets	696,518	717,265	609,968	594,428	599,853	477,646
Accounts Payable	12,682	5,014	3,423	2,734	4,186	3,920
Accrued Expenses	5,232	4,445	2,683	2,556	4,117	8,410
Short-Term Debt	100,579	101,114	35,784	46,631	49,763	398,613
Current Portion of Long-Term Debt	47,000	45,000	45,000	44,938	7,675	-
Current Portion of Leases	863.25	1,030	592.23	560.08	934.88	2,785
Current Income Taxes Payable	-	-	246.72	-	4.18	-
Current Unearned Revenue	696.15	234.25	-	-	-	-
Other Current Liabilities	29,454	26,932	25,231	28,222	23,253	8,202
Total Current Liabilities	196,506	183,769	112,959	125,640	89,933	421,929
Long-Term Debt	38,000	40,000	32,000	32,000	31,251	31,046
Long-Term Leases	652.43	718.46	326.69	288.35	571.03	19,925
Pension & Post-Retirement Benefits	15,980	16,835	15,694	11,740	10,319	4,076
Long-Term Deferred Tax Liabilities	8,717	8,734	6,590	5,375	5,322	1,167
Other Long-Term Liabilities	5,844	8,598	2,308	1,696	1,455	309.39
Total Liabilities	265,699	258,655	169,878	176,740	138,851	478,453
Common Stock	164,653	164,653	152,062	132,419	126,834	260,351
Additional Paid-In Capital	521,804	521,069	512,886	472,949	431,641	46,794
Retained Earnings	-510,220	-488,200	-418,506	-358,604	-293,691	-192,837
Treasury Stock	-98,115	-98,115	-98,115	-98,115	-98,084	-
Comprehensive Income & Other	62,474	58,904	10,306	-849.67	48,392	-112,146
Total Common Equity	140,596	158,310	158,634	147,800	215,092	2,163
Minority Interest	290,223	300,300	281,457	269,888	245,910	-2,970
Shareholders' Equity	430,819	458,610	440,091	417,688	461,002	-806.44
Total Liabilities & Equity	696,518	717,265	609,968	594,428	599,853	477,646
Total Debt	187,095	187,862	113,702	124,417	90,195	452,369
Net Cash (Debt)	-146,633	-137,102	-70,041	-83,732	-42,736	-432,475
Net Cash Per Share	-7276.63	-6913.76	-4070.09	-5318.10	-3167.42	-37416.92
Filing Date Shares Outstanding	308.55	20.57	18.89	16.27	15.53	4.43
Total Common Shares Outstanding	308.55	20.57	18.89	16.27	15.53	4.43
Working Capital	-29,989	-5,126	21,357	18,567	121,644	-318,829
Book Value Per Share	455.67	7696.27	8397.29	9083.11	13851.34	488.78
Tangible Book Value	72,253	89,938	152,528	140,311	206,661	-469.92
Tangible Book Value Per Share	234.17	4372.33	8074.10	8622.88	13308.41	-106.18
Land	60,081	60,081	50,012	44,136	44,190	12,484
Buildings	122,711	122,711	115,772	115,622	113,611	88,041
Machinery	268,416	268,124	221,978	195,122	191,265	137,051
Construction In Progress	29,139	29,566	61,140	107,580	88,234	85,017